首页|期刊导航|上海针灸杂志|头穴埋线联合中药治疗阿尔兹海默病的疗效观察及对可溶性凋亡因子的影响

头穴埋线联合中药治疗阿尔兹海默病的疗效观察及对可溶性凋亡因子的影响OA

Observation on the efficacy of catgut-embedding therapy at scalp acupoints combined with Chinese medicines in the treatment of Alzheimer disease and its effect on soluble apoptotic factor

中文摘要英文摘要

目的 观察头穴埋线联合益肾益智汤治疗肾精亏虚型阿尔兹海默病的临床疗效及其对患者血清可溶性凋亡因子(soluble apoptosis-related factor,sFas)、淀粉蛋白前β 位分解酶 1(Amyloproposition β resolvase 1,BACE1)、单核细胞趋化蛋白-1(monocyte chemoattractant protein-1,MCP-1)和丙二醛(malondi-aldehyde,MDA)水平的影响.方法 选取 136 例肾精亏虚型阿尔兹海默病患者为研究对象,按随机数字表法分为对照组(68 例)和观察组(68 例).对照组采用西医常规治疗,观察组在对照组治疗基础上另予头穴埋线联合益肾益智汤治疗.观察两组治疗前后中医证候积分、阿尔茨海默病评估量表-认知分量表(Alzheimer disease assessment scale-cog,ADAS-cog)评分、简易精神状态量表(mini-mental state examination,MMSE)评分以及血清sFas、BACE1、MCP-1、MDA、脑源性神经营养因子(brain-derived neurotrophic factor,BDNF)、去甲肾上腺素(noradrenaline,NE)和血管内皮生长因子(vascular endothelial growth factor,VEGF)水平的变化,比较两组临床疗效和不良反应发生情况.结果 观察组总有效率高于对照组,差异具有统计学意义(P<0.05).治疗后,两组中医证候积分、ADAS-cog评分和MMSE评分均较治疗前改善(P<0.05),且观察组上述评分均优于对照组(P<0.05).观察组治疗后血清sFas、BACE1和MDA水平均低于对照组(P<0.05),血清BDNF、NE和VEGF水平均高于对照组(P<0.05).两组治疗后血清MCP-1 水平比较,差异无统计学意义(P>0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 在西医常规治疗基础上,头穴埋线联合益肾益智汤治疗肾精亏虚型阿尔兹海默病可提高临床疗效,有助于减轻炎症反应,可进一步改善氧化应激失衡,提高认知水平.

Objective To observe the clinical efficacy of catgut-embedding therapy at scalp acupoints combined with Yi Shen Yi Zhi decoction in the treatment of Alzheimer disease of kidney essence deficiency pattern and its effect on serum soluble apoptosis-related factor(sFas),amyloproposition β resolvase 1(BACE1),monocyte chemoattractant protein-1(MCP-1)and malondi-aldehyde(MDA).Method A total of 136 patients with Alzheimer disease of kidney essence deficiency pattern were selected as the study objects and divided into a control group(68 patients)and an observation group(68 patients)according to the random number table method.The control group was treated with conventional Western medicine,while the observation group was treated with catgut-embedding therapy at scalp acupoints combined with Yi Shen Yi Zhi decoction in addition to the treatment in the control group.Before and after the treatment,the traditional Chinese medicine(TCM)pattern score,Alzheimer disease assessment scale-cog(ADAS-cog)score,mini-mental state examination(MMSE)score,and serum sFas,BACE1,MCP-1,MDA,brain-derived neurotrophic factor(BDNF),noradrenaline(NE)and vascular endothelial growth factor(VEGF)levels were observed in the two groups,and the clinical efficacy and occurrence of adverse reactions between the two groups were compared.Result The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After the treatment,the TCM pattern scores,ADAS-cog scores and MMSE scores of both groups improved compared with those before treatment(P<0.05),and the above scores of the observation group were better than those of the control group(P<0.05).After treatment,the serum sFas,BACE1 and MDA levels of the observation group were lower than those of the control group(P<0.05),and the serum BDNF,NE and VEGF levels were higher than those of the control group(P<0.05).There was no statistically significant difference in serum MCP-1 levels between the two groups after treatment(P>0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion On the basis of conventional treatment in Western medicine,the combination of catgut-embedding therapy at scalp acupoints and Yi Shen Yi Zhi decoction in the treatment of Alzheimer disease of kidney essence deficiency pattern can improve the clinical efficacy,help to reduce the inflammatory response,and further improve the imbalance of oxidative stress and cognitive level.

袁艳;陶录岭;张举孔

河南省南阳市第二人民医院,南阳 473012河南省南阳市第二人民医院,南阳 473012河南省南阳市第二人民医院,南阳 473012

中医学

埋线穴位,头颈部中药阿尔兹海默病痴呆肾精亏虚

Catgut-embedding therapyPoints,Head and neckTraditional Chinese drugsAlzheimer diseaseDementiaKidney essence deficiency

《上海针灸杂志》 2025 (2)

190-195,6

河南省中医药科学研究专项课题(2022ZY1203)

10.13460/j.issn.1005-0957.2025.02.0190

评论